News
AgNovos Bioscience Announces 150th Patient Enrolled in RESTORE
AgNovos Bioscience announces that more than 150 patients have been enrolled in the RESTORE randomized, controlled trial of AGN1 LOEP.
News & Events
Keep up to date on AgNovos events and related news
Featured posts
All Articles
AgNovos Healthcare Will Attend World Congress on Osteoporosis
AgNovos Healthcare will once again attend WCO.
AgNovos Healthcare at Alterstraumatologie Congress 2018, 22 & 23 March (Zürich, Switzerland)
AgNovos Healthcare will exhibit at the Alterstraumatologie Kongress in Zürich and hold a symposium on the 22nd March.
STRONG Clinical Study Interim Results Presented at Alterstraumatologie Congress 2018
During Alterstramatologie congress, Dr. Christian Fang presented a poster featuring the interim results of the ongoing STRONG clinical study.
AgNovos Researcher Recognized at ORS (Orthopedic Research Society) Meeting
At the ORS 2018 Annual Meeting in New Orleans, Dr. Jonathan Shaul (PhD), AgNovos Sr. Research Engineer, was selected as a finalist for both the New Investigator Recognition Award (NIRA) and ORS Preclinical Models Section Member Podium Award for his presentation: "Injectable Triphasic Biomaterial Resorbs and Increases Bone Formation in Ovariectomized Rat Metaphyseal Defects of the Femur".
AgNovos Healthcare Hires Mr. Falk Dukatz as Vice President Global Sales
AgNovos Healthcare is pleased to announce that it has hired Falk Dukatz as Vice President of Global Sales.
Dr. James Howe to Lecture on OSSURE LOEP during Ortomed Conference
During the Ortomed Conference in Florence, Italy, Dr. James Howe will present the rationale and the science supporting OSSURE LOEP (Local Osteo-Enhancement Procedure), an emerging treatment for osteoporosis-related bone loss in the proximal femur.